INS and Glucose intolerance: Likewise, 4 weeks of insulin treatment did not affect HFD-induced upregulation of SA-β-gal activity in gWAT, body weight or gWAT weight, although glucose intolerance and insulin resistance were significantly improved compared with the control HFD group (Extended Data Fig. 4a–d and Supplementary Fig. 1e).